Answers are grounded in this paper and cite their sources.
This review focuses on a description of the Argus II retinal prosthesis system (Argus II; Second Sight Medical Products, Sylmar, CA) that was approved for humanitarian use by the FDA in 2013 in patients with retinitis pigmentosa with bare or no light perception vision. The article describes the components of Argus II, the studies on the implant, and future directions.
No takes yet. Share an insight, caveat, or question.
Rachitskaya et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: